Novorapid vs Humalog

Comparing NovoRapid vs Humalog can help shed some light on a few key points.

What is NovoRapid?

NovoRapid is the tradename for insulin aspart. It is a rapid-acting human insulin analog that aims to treat patients with diabetes mellitus that need insulin therapy. It is normally used immediately before a meal to regulate blood sugar levels after meals. It functions within 20 minutes, peaks at 1 to 3 hours, and lasts for about 3 to 5 hours. Since it functions quickly, time the meals carefully as missed meals can result in dangerously low levels of blood sugar, which is commonly referred to as hypoglycemia. Hypoglycemia is a potentially fatal condition where low blood sugar levels are insufficient to support bodily functions. Always carry sweets or glucose tablets and consume them immediately if you find yourself feeling dizzy, have blurred vision, sweating profusely, and have tremors. Do not attempt to drive or operate any heavy machinery if these symptoms occur. Seek medical attention immediately. NovoRapid is also typically used with either intermediate- or long-acting insulin, as they function to keep blood sugar levels regulated during periods of fasting.

What is Humalog?

Humalog, on the other hand, is known as insulin lispro. It is also a rapid-acting human insulin that has a very similar time lapse and indication with NovoRapid.

Difference between NovoRapid vs Humalog

A study that compared both Humalog and NovoRapid found no significant differences between the two in terms of blood sugar control and side effect profile. For example, the risk of lipodystrophy is noted with the use of either of these medications. Lipodystrophy is when your fat cells become thinner or thickened due to repeated insulin injections in the same area. When lipodystrophy occurs, insulin will be absorbed differently when you inject either NovoRapid or Humalog into the affected area. This can unexpectedly cause hypoglycemia or poor blood sugar control.